Matthew W. Emmens
2011
In 2011, Matthew W. Emmens earned a total compensation of $13.4M as Former Chairman, President CEO at Vertex Pharmaceuticals, a 10% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $3,019,587 |
|---|---|
| Option Awards | $7,343,482 |
| Salary | $1,163,068 |
| Stock Awards | $1,830,927 |
| Other | $1,470 |
| Total | $13,358,534 |
Emmens received $7.3M in option awards, accounting for 55% of the total pay in 2011.
Emmens also received $3M in non-equity incentive plan, $1.2M in salary, $1.8M in stock awards and $1.5K in other compensation.
Rankings
In 2011, Matthew W. Emmens' compensation ranked 193rd out of 10,747 executives tracked by ExecPay. In other words, Emmens earned more than 98.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 193 out of 10,747 | 98th |
Division Manufacturing | 61 out of 3,960 | 99th |
Major group Chemicals And Allied Products | 18 out of 1,033 | 98th |
Industry group Drugs | 10 out of 781 | 99th |
Industry Pharmaceutical Preparations | 9 out of 571 | 98th |
Source: SEC filing on April 4, 2013.
Emmens' colleagues
We found four more compensation records of executives who worked with Matthew W. Emmens at Vertex Pharmaceuticals in 2011.